...Good morning. I'm Sean McClain, the Founder and CEO of Absci. We're a generative AI drug creation company, looking to use generative design, solve some of the toughest problems in biology that still exist to ultimately get differentiated assets to patients faster. We've always been a data-first company. Our original technology was scaling protein-protein interactions going from screening thousands of antibodies to millions. And we've leveraged this technology to build out a world-class AI platform. It was a purpose-built team. We have world-class scientists that have over 10 drugs approved under leadership and an amazing AI team that comes from OpenAI, Google, Tesla and NVIDIA. Additionally, we have an integrated data flywheel, which I'll get more into on subsequent slides, where we're able to use this wet lab technology to generate data for training and use that same technology for validation. We like to call this our lab in the loop. We use these models to ultimately create differentiated...
